|1.||Koga, Masafumi: 29 articles (01/2016 - 03/2007)|
|2.||Kasayama, Soji: 15 articles (12/2015 - 03/2007)|
|3.||Zhang, Rui Yan: 9 articles (10/2015 - 01/2006)|
|4.||Zhang, Qi: 9 articles (10/2015 - 01/2006)|
|5.||Shen, Wei Feng: 9 articles (10/2015 - 01/2006)|
|6.||Lu, Lin: 9 articles (10/2015 - 01/2006)|
|7.||Saito, Hiroshi: 9 articles (05/2013 - 03/2007)|
|8.||Pu, Li Jin: 8 articles (10/2015 - 01/2006)|
|9.||Selvin, Elizabeth: 8 articles (07/2015 - 04/2011)|
|10.||Murai, Jun: 8 articles (05/2013 - 07/2010)|
|1.||Diabetic Nephropathies (Diabetic Nephropathy)
05/01/2000 - "We conclude that normalization of plasma glycated albumin concentrations with the glycation inhibitor EXO-226 ameliorates the glomerular structural and functional abnormalities associated with diabetic nephropathy in the db/db mouse."
02/01/1996 - "These studies implicate Amadori-modified glycated albumin in the pathogenesis of diabetic nephropathy. "
01/01/2015 - "This review is an approach to compile both the nature of glycated albumin as a damaging agent of tissues and as an intermediate diagnostic marker and its potential role in diabetic nephropathy. "
01/01/2015 - "Glycated albumin is reported to elicit pathobiologic effects in diabetic nephropathy and abrogating its biologic effects has novel therapeutic potential. "
01/01/2006 - "Urine glycosyl albumin is an important finding in the patients with severe diabetic nephropathy. "
01/01/2016 - "Measured glycated albumin concentrations in patients with transient neonatal diabetes mellitus in remission were lower than the reference range for adults, whereas age-adjusted glycated albumin concentrations were within the reference range for adults. "
01/01/2016 - "In the present study, we evaluate the usefulness of age-adjusted glycated albumin in neonatal diabetes mellitus patients. "
12/01/2011 - "Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS)."
01/01/2016 - "The Committee on Diabetes Mellitus Indices of the Japan Society of Clinical Chemistry recommends the isotope dilution liquid chromatography/tandem mass spectrometry method as a reference measurement procedure, and JCCRM611 as a certified reference material for glycated albumin measurement. "
01/01/2016 - "Committee on Diabetes Mellitus Indices of the Japan Society of Clinical Chemistry-recommended reference measurement procedure and reference materials for glycated albumin determination."
|3.||Coronary Artery Disease (Coronary Atherosclerosis)
08/14/2012 - "To explore the associations of the level of glycated albumin (GA) with coronary artery disease (CAD). "
08/14/2012 - "[Associations of glycated albumin level with coronary artery disease]."
10/01/2009 - "Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes."
07/01/2007 - "Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients."
07/01/2007 - "The aim of this study was to assess the relationship between increased serum glycated albumin level and the presence and severity of coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM). "
05/01/2000 - "Administration of EXO-226 (3 mg/kg) twice daily by gavage normalized the plasma concentration of glycated albumin within days after initiation of treatment and maintained glycated albumin within the normal range throughout the study, despite persistent and severe hyperglycemia. "
01/01/2015 - "Novel data are included showing how AGEs (especially glycated albumin) may be involved in hyperglycemia-induced oxidative damage in adipocytes and its potential links to diabetes progression. "
07/05/2013 - "We identified increased ADA2 expression and activity in human and porcine retinas with diabetes, and in Amadori glycated albumin (AGA)- or hyperglycemia-treated porcine and human microglia. "
01/01/2011 - "Glycated albumin (GA) is an Amadori product used as a marker of hyperglycemia. "
09/01/1979 - "Because albumin has a shorter circulating half-life than does the human erythrocyte, the plasma concentration of glucosylated albumin should be expected to reflect short-term control of hyperglycemia in diabetes. "
|5.||Renal Insufficiency (Renal Failure)
03/15/2013 - "The relationship between HbA(1c) and glycated albumin (GA) in patients with and without renal failure was also compared. "
07/31/2013 - "Impact of elevated serum glycated albumin levels on contrast-induced acute kidney injury in diabetic patients with moderate to severe renal insufficiency undergoing coronary angiography."
01/01/2006 - "Giving out the energy from the nearby cellular compartment during formation of glycosyl albumin might be an important pathological process leading to severe diabetic nephropathy and renal failure."
07/01/2007 - "A significant difference was found in glycated albumin, hsCRP and TNF-alpha levels among diabetic patients with mild, moderate renal insufficiency and normal renal function (P<0.05). "
07/01/2002 - "Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice."
|3.||Proteins (Proteins, Gene)
|4.||Glycosylated Hemoglobin A (Glycosylated Hemoglobin)
|6.||Collagen Type IV (Type IV Collagen)
|7.||Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
|8.||Extracellular Matrix Proteins
|9.||Transforming Growth Factor beta (TGF-beta)
|2.||Renal Dialysis (Hemodialysis)